Abstract:Glioma, as the most frequently occurring primary malignancy in the central nervous system, significantly impacts patients' quality of life and cognitive abilities. Ferroptosis, a newly discovered form of cell death, is characterized by significant iron accumulation and lipid peroxidation. This process is fundamentally dependent on iron. Various factors inducing ferroptosis can either directly or indirectly influence glutathione peroxidase, leading to reduced antioxidant capabilities and an increase in lipid reactive oxygen species (ROS) within cells, culminating in oxidative cell death. Recent research indicates a strong connection between ferroptosis and a range of pathophysiological conditions, including tumors, neurological disorders, ischemia-reperfusion injuries, kidney damage, and hematological diseases. The regulation of ferroptosis to intervene in the progression of these diseases has emerged as a major area of interest in etiological research and therapy. However, the exact functional alterations and molecular mechanisms underlying ferroptosis remain to be extensively studied. The review firstly explores the intricate relationship between ferroptosis and glioma, highlighting how ferroptosis contributes to glioma pathogenesis and how glioma cells may resist this form of cell death. Then, we discuss recent studies that have identified potential ferroptosis inducers and inhibitors, which could serve as novel therapeutic strategies for glioma. We also examine the current challenges in targeting ferroptosis in glioma treatment, including the complexity of its regulation and the need for precise delivery methods. This review aims to provide a comprehensive overview of the current state of research on ferroptosis in glioma, offering insights into future therapeutic strategies and the broader implications of this novel cell death pathway in cancer biology.

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities

Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles

Emerging Roles of Ferroptosis in Glioma

Targeting ferroptosis opens new avenues in gliomas

Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma

Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment

The Molecular Mechanisms of Ferroptosis and Its Role in Glioma Progression and Treatment

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma

Visualization of ferroptosis in brain diseases and ferroptosis-inducing nanomedicine for glioma

Deciphering the link: ferroptosis and its role in glioma

Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations

Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme

Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Targeting Ferroptosis in Gastric Cancer: Strategies and Opportunities